Sverdlov AL - Search Results

1

Pharmacist-led medication management services: a qualitative exploration of transition-of-care cardiovascular disease patient experiences.

Bennetts J, White J, Croft H, Cooper J, McIvor D, Eadie N, Appay M, Sverdlov AL, Ngo D. Bennetts J, et al. Among authors: sverdlov al. BMJ Open. 2024 May 22;14(5):e082228. doi: 10.1136/bmjopen-2023-082228. BMJ Open. 2024. PMID: 38777587 Free PMC article.

2

Correlates of arterial stiffness in an ageing population: role of asymmetric dimethylarginine.

Ngo DT, Sverdlov AL, McNeil JJ, Horowitz JD. Ngo DT, et al. Among authors: sverdlov al. Pharmacol Res. 2009 Dec;60(6):503-7. doi: 10.1016/j.phrs.2009.06.006. Epub 2009 Jun 25. Pharmacol Res. 2009. PMID: 19559793

3

Determinants of occurrence of aortic sclerosis in an aging population.

Ngo DT, Sverdlov AL, Willoughby SR, Nightingale AK, Chirkov YY, McNeil JJ, Horowitz JD. Ngo DT, et al. Among authors: sverdlov al. JACC Cardiovasc Imaging. 2009 Aug;2(8):919-27. doi: 10.1016/j.jcmg.2009.03.016. JACC Cardiovasc Imaging. 2009. PMID: 19679278 Free article.

4

Lack of association between aortic sclerosis and left ventricular hypertrophy in elderly subjects.

Nightingale AK, Sverdlov AL, Rajendran S, Mishra K, Heresztyn T, Ngo DT, Horowitz JD. Nightingale AK, et al. Among authors: sverdlov al. Int J Cardiol. 2011 Jul 1;150(1):33-8. doi: 10.1016/j.ijcard.2010.02.024. Epub 2010 Mar 16. Int J Cardiol. 2011. PMID: 20236713

5

Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations?

Ngo DT, Sverdlov AL, McNeil JJ, Horowitz JD. Ngo DT, et al. Among authors: sverdlov al. Am J Med. 2010 Apr;123(4):335-41. doi: 10.1016/j.amjmed.2009.09.024. Am J Med. 2010. PMID: 20362753

6

Pathogenesis of aortic stenosis: not just a matter of wear and tear.

Sverdlov AL, Ngo DT, Chapman MJ, Ali OA, Chirkov YY, Horowitz JD. Sverdlov AL, et al. Am J Cardiovasc Dis. 2011;1(2):185-99. Epub 2011 Jul 28. Am J Cardiovasc Dis. 2011. PMID: 22254198 Free PMC article.

7

Pathogenesis of aortic sclerosis: association with low BMI, tissue nitric oxide resistance, but not systemic inflammatory activation.

Sverdlov AL, Ngo DT, Horowitz JD. Sverdlov AL, et al. Am J Cardiovasc Dis. 2012;2(1):43-9. Epub 2011 Dec 15. Am J Cardiovasc Dis. 2012. PMID: 22254213 Free PMC article.

8

Prevention of aortic valve stenosis: a realistic therapeutic target?

Ngo DT, Sverdlov AL, Horowitz JD. Ngo DT, et al. Among authors: sverdlov al. Pharmacol Ther. 2012 Jul;135(1):78-93. doi: 10.1016/j.pharmthera.2012.04.001. Epub 2012 Apr 6. Pharmacol Ther. 2012. PMID: 22516738 Review.

9

Determinants of aortic sclerosis progression: implications regarding impairment of nitric oxide signalling and potential therapeutics.

Sverdlov AL, Ngo DT, Chan WP, Chirkov YY, Gersh BJ, McNeil JJ, Horowitz JD. Sverdlov AL, et al. Eur Heart J. 2012 Oct;33(19):2419-25. doi: 10.1093/eurheartj/ehs171. Epub 2012 Jul 6. Eur Heart J. 2012. PMID: 22771677

10

Heart failure: a corin-deficient state?

Ngo DT, Horowitz JD, Sverdlov AL. Ngo DT, et al. Among authors: sverdlov al. Hypertension. 2013 Feb;61(2):284-5. doi: 10.1161/HYPERTENSIONAHA.112.196253. Epub 2012 Dec 10. Hypertension. 2013. PMID: 23232647 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters